16 May 2022

India: Holcim has agreed to sell its Indian business to industry, energy and ports conglomerate Adani Group for US$6.37bn. The assets consist of a 63% stake in Ambuja Cement, which in turn owns 50% of ACC, and a 4.5% direct stake in ACC.

ACC and Ambuja Cement employ 10,700 people and operate 31 cement plants in India. The deal will make Adani Group India’s second-largest cement producer.

Chair Gautam Adani said "With Holcim's global leadership in sustainability, we are acquiring some of the most efficient building materials operations in India, powered with clean technologies like heat recovery systems. We recognise that Ambuja and ACC operations are energy intensive and therefore, when combined with our renewable power generation capabilities, we gain a big head start in the decarbonisation journey that is a must for Indian industry."

Holcim says that its focus is now on expanding its solutions and products business. Reuters News has reported that the group plans to put the proceeds of the assets’ sale towards lower-carbon acquisitions. Its Indian operations contributed 26% of group CO₂ emissions.

Chief executive officer Jan Jenisch said "We will always make cement, but we will decarbonise cement.” He added “We are happy to build up other segments like building solutions and products."

Peru: Cementos Pacasmayo recorded consolidated sales of US$140m in the first quarter of 2022, up by 13% year-on-year from US$124m in the first quarter of 2021. Its earnings before interest, taxation, depreciation and amortisation (EBITDA) also rose, by 21% year-on-year to US$128m from US$105m. The company said that its strong revenue generation enabled earnings growth despite cost increases. Its reliance on imported clinker to meet growing demand increased Cementos Pacasmayo’s exposure to the effects of inflation.

During the quarter, Cementos Pacasmayo produced 882,000t of cement across its three facilities, down by 4.4% year-on-year. The plants’ clinker production rose by 6.7% to 568Mt from 532Mt in the first quarter of 2021.

Russia: Holcim said that it has received interest from over 30 possible buyers for its Russian business. The group announced that it would sell the assets, including three cement plants, in March 2022, after the Russian invasion of Ukraine on 24 February 2022.

Chief executive officer (CEO) Jan Jenisch said that the sale would need to be handled ‘with very great diligence.’ He continued "We don't expect to write it off completely. I would hope this business has a value." Jenisch asked investors and commentators to ‘give us a couple of months’ to ‘get more clarity.’

UK: Mannok recorded sales of Euro270m in 2021, up by 16% year-on-year from Euro233m in 2020. The company’s earnings before interest, taxation, depreciation and amortisation (EBITDA) fell by 17% to Euro25.8m from Euro31.1m. The group attributed this to substantial cost absorption beginning in mid-2021. Energy prices rose by 66% year-on-year, while the cost of carbon emissions trading scheme (ETS) credits more than doubled to Euro80/t at the end of the year.

Mannok said that demand for its products remains resilient, supported by stronger cost recovery. It added that a levelling out in energy prices has driven stronger profitability in the first quarter and April of 2022.

Philippines: Holcim Philippines has donated 3000 Covid-19 vaccinations to the Lorma Medical Center in San Fernando, La Union. The Business Mirror newspaper has reported that the company aims to help increase inoculation levels in remote parts of the province, at a time when tourism is beginning again.

Vice president and head of communications and corporate social responsibility Cara Ramirez said “We are thankful to the Lorma Medical Center for being our partner in providing vaccines to our neighbours in La Union. We are hopeful that this donation will further strengthen the province's resilience against the disease as we enter summer and tourism once again booms. While the pandemic appears to be easing, we need to remain vigilant and encourage everyone to avail themselves of the vaccines to be more protected.”